Arizona State Retirement System’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.08M | Sell |
5,407
-99
| -2% | -$19.6K | 0.01% | 1052 |
|
|
2025
Q4 | $1.04M | Sell |
5,506
-194
| -3% | -$37.3K | 0.01% | 1089 |
|
|
2025
Q3 | $1.01M | Buy |
5,700
+103
| +2% | +$15.3K | 0.01% | 1136 |
|
|
2025
Q2 | $636K | Buy |
5,597
+190
| +4% | +$20.3K | ﹤0.01% | 1332 |
|
|
2025
Q1 | $568K | Buy |
5,407
+110
| +2% | +$12.4K | ﹤0.01% | 1362 |
|
|
2024
Q4 | $568K | Buy |
5,297
+125
| +2% | +$14.1K | ﹤0.01% | 1424 |
|
|
2024
Q3 | $518K | Buy |
5,172
+464
| +10% | +$46.7K | ﹤0.01% | 1463 |
|
|
2024
Q2 | $397K | Buy |
4,708
+156
| +3% | +$12.4K | ﹤0.01% | 1558 |
|
|
2024
Q1 | $333K | Sell |
4,552
-58
| -1% | -$4.28K | ﹤0.01% | 1667 |
|
|
2023
Q4 | $329K | Sell |
4,610
-62
| -1% | -$3.66K | ﹤0.01% | 1675 |
|
|
2023
Q3 | $280K | Buy |
4,672
+115
| +3% | +$7.57K | ﹤0.01% | 1712 |
|
|
2023
Q2 | $329K | Sell |
4,557
-338
| -7% | -$25.4K | ﹤0.01% | 1662 |
|
|
2023
Q1 | $360K | Buy |
4,895
+132
| +3% | +$9.38K | ﹤0.01% | 1588 |
|
|
2022
Q4 | $318K | Sell |
4,763
-2,582
| -35% | -$168K | ﹤0.01% | 1640 |
|
|
2022
Q3 | $395K | Buy |
7,345
+85
| +1% | +$5K | ﹤0.01% | 1461 |
|
|
2022
Q2 | $404K | Buy |
7,260
+19
| +0.3% | +$1.08K | ﹤0.01% | 1491 |
|
|
2022
Q1 | $508K | Buy |
7,241
+47
| +0.7% | +$3.41K | ﹤0.01% | 1462 |
|
|
2021
Q4 | $693K | Sell |
7,194
-77
| -1% | -$7.11K | 0.01% | 1330 |
|
|
2021
Q3 | $632K | Buy |
7,271
+32
| +0.4% | +$2.48K | 0.01% | 1396 |
|
|
2021
Q2 | $592K | Sell |
7,239
-265
| -4% | -$22K | ﹤0.01% | 1465 |
|
|
2021
Q1 | $714K | Buy |
7,504
+34
| +0.5% | +$3.21K | 0.01% | 1332 |
|
|
2020
Q4 | $463K | Sell |
7,470
-292
| -4% | -$16.6K | ﹤0.01% | 1496 |
|
|
2020
Q3 | $462K | Buy |
7,762
+1,791
| +30% | +$122K | ﹤0.01% | 1362 |
|
|
2020
Q2 | $417K | Sell |
5,971
-638
| -10% | -$40.4K | 0.01% | 1218 |
|
|
2020
Q1 | $300K | Sell |
6,609
-9,355
| -59% | -$530K | 0.01% | 1286 |
|
|
2019
Q4 | $1.04M | Sell |
15,964
-3,028
| -16% | -$202K | 0.01% | 1070 |
|
|
2019
Q3 | $1.18M | Sell |
18,992
-3,809
| -17% | -$239K | 0.01% | 1157 |
|
|
2019
Q2 | $1.62M | Sell |
22,801
-733
| -3% | -$54K | 0.02% | 1102 |
|
|
2019
Q1 | $1.85M | Sell |
23,534
-920
| -4% | -$69.7K | 0.02% | 1034 |
|
|
2018
Q4 | $2.07M | Sell |
24,454
-24,620
| -50% | -$2.62M | 0.03% | 897 |
|
|
2018
Q3 | $8.4M | Sell |
49,074
-678
| -1% | -$102K | 0.08% | 309 |
|
|
2018
Q2 | $6.43M | Sell |
49,752
-3,585
| -7% | -$400K | 0.06% | 373 |
|
|
2018
Q1 | $5.5M | Sell |
53,337
-3,526
| -6% | -$349K | 0.06% | 447 |
|
|
2017
Q4 | $4.86M | Buy |
56,863
+39,430
| +226% | +$3.42M | 0.05% | 539 |
|
|
2017
Q3 | $1.48M | Buy |
17,433
+1,443
| +9% | +$114K | 0.02% | 847 |
|
|
2017
Q2 | $1.21M | Buy |
15,990
+160
| +1% | +$11.2K | 0.02% | 843 |
|
|
2017
Q1 | $1.04M | Buy |
15,830
+161
| +1% | +$10.6K | 0.01% | 903 |
|
|
2016
Q4 | $993K | Hold |
15,669
| – | – | 0.01% | 930 |
|
|
2016
Q3 | $998K | Sell |
15,669
-161
| -1% | -$11.8K | 0.02% | 881 |
|
|
2016
Q2 | $1.18M | Buy |
15,830
+962
| +6% | +$71.4K | 0.02% | 767 |
|
|
2016
Q1 | $993K | Buy |
14,868
+481
| +3% | +$29.2K | 0.01% | 888 |
|
|
2015
Q4 | $973K | Buy |
14,387
+481
| +3% | +$29.7K | 0.01% | 888 |
|
|
2015
Q3 | $743K | Buy |
+13,906
| New | +$844K | 0.01% | 988 |
|
|
2014
Q4 | $675K | Sell |
20,358
-641
| -3% | -$20.9K | 0.01% | 1222 |
|
|
2014
Q3 | $615K | Sell |
20,999
-4,168
| -17% | -$138K | 0.01% | 1222 |
|
|
2014
Q2 | $977K | Buy |
25,167
+1,443
| +6% | +$58.6K | 0.01% | 1089 |
|
|
2014
Q1 | $995K | Sell |
23,724
-2,405
| -9% | -$100K | 0.01% | 1049 |
|
|
2013
Q4 | $857K | Buy |
+26,129
| New | +$851K | 0.01% | 1168 |
|
Other funds holding LGND
VPM
VCM
NAMI
CC
Arizona State Retirement System's LGND Position: Q1 2026 in Review
Arizona State Retirement System reduced its Ligand Pharmaceuticals (LGND) stake by 1.8% in Q1 2026, selling an estimated $19.6K and leaving 5,407 shares worth $1.08M. The position accounts for 0.01% of the portfolio, ranked #1052.
Arizona State Retirement System first reported a position in LGND in Q4 2013 and has held it in 48 quarters since. The position peaked at $8.4M in Q3 2018. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.
- Arizona State Retirement System held 5,407 shares of Ligand Pharmaceuticals worth $1.08M as of Q1 2026.
- Arizona State Retirement System sold 99 Ligand Pharmaceuticals shares in Q1 2026, an estimated $19.6K.
- Ligand Pharmaceuticals made up 0.01% of Arizona State Retirement System's portfolio in Q1 2026, its #1052 holding.
- Arizona State Retirement System first reported a position in Ligand Pharmaceuticals in Q4 2013 and has held it in 48 quarters since.
- Arizona State Retirement System's Ligand Pharmaceuticals position peaked at $8.4M in Q3 2018.
- 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.
Based on Arizona State Retirement System's 13F filing for Q1 2026, filed 1 May 2026.